ARVD2 phenotypes mimic and overlap with CPVT phenotypes since structural abnormalities (myocyte loss with fatty or fibro-fatty tissue replacement predominantly of the right ventricle) frequently lack or remain undetected using non-invasive imaging methods. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.